Skip to content

Subscriptions are live.

Plans
Logo
Start Free

Why is $ELTP stock moving today?

ELITE PHARMS INC

Why is $ELTP moving today?

The likely driver

Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 ended June 30, 2026
ELITE PHARMACEUTICALS INC /NV/: Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 ended June 30, 2026
SEC filing · Aug 13
Price
$0.25
Move today
+0.0%
Scanner alerts today
0
Flagged in 30 days
8
Prev close
$0.25

Nothing has triggered on ELTP yet in this session. Our scanner has flagged it 8 times in the last 30 days , most recently on October 15 for big percentage moves, unusual volume, which is why this page is here. See the full ELTP page for the chart and the alert history.

Earlier scanner activity on ELTP

  • Oct 15Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert
  • Oct 5Unusual volume (RVOL) alert
  • Oct 5Big % mover alert
  • Oct 5Unusual volume (RVOL) alert
  • Sep 29Unusual volume (RVOL) alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Full $ELTP page →Live chartTrending stocks
Free alerts

Get free $ELTP alerts the moment volume spikes

Our scanner flagged $ELTP 8 times in the last 30 days. Create a free account to track $ELTP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

$VXX +7.6%$MODD +7.2%$GRNT +7.1%$PAYP +7.0%$MTDR +7.0%$WNTR +6.6%$VWAV +6.2%$AR +6.1%

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.